Sol-Gel Technologies, Ltd.   Report issue

For profit Phase 2 Phase 3
Founded: Ness Ziona Israel (1997)
Status: No NME R&D (1997)

Organization Overview

First Clinical Trial
2012
NCT00940992
First Marketed Drug
2021
tretinoin (Retin-A)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

SOL-GEL TECHNOLOGIES | Sol-Gel Technologies, Ltd.